Cargando…
Lack of Immunotherapy as the Only Predictor of Secondary Generalization in Very-Late-Onset Myasthenia Gravis With Pure Ocular Onset
During the past two decades, an increasing number of patients with very-late-onset myasthenia gravis (v-LOMG) with an onset age of 65 years or older have been identified. However, few studies explore the predictors of secondary generalization in patients with v-LOMG with pure ocular onset. In this r...
Autores principales: | Zhao, Sijia, Yan, Xu, Ding, Jiaqi, Ren, Kaixi, Sun, Shuyu, Lu, Jiarui, Zhang, Chao, Zhang, Kai, Li, Zhuyi, Guo, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081806/ https://www.ncbi.nlm.nih.gov/pubmed/35547386 http://dx.doi.org/10.3389/fneur.2022.857402 |
Ejemplares similares
-
Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China
por: Ding, Jiaqi, et al.
Publicado: (2020) -
Prediction of the generalization of myasthenia gravis with purely ocular symptoms at onset: a multivariable model development and validation
por: Li, Feng, et al.
Publicado: (2022) -
Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study
por: Zhao, Sijia, et al.
Publicado: (2021) -
Human Leucocyte Antigen B50 Is Associated with Conversion to Generalized Myasthenia Gravis in Patients with Pure Ocular Onset
por: Tiftikcioglu, Bedile Irem, et al.
Publicado: (2017) -
Dynamic nomogram for predicting generalized conversion in adult-onset ocular myasthenia gravis
por: Bi, Zhuajin, et al.
Publicado: (2022)